Increased expression of class I HDACs has been reported in cell lines derived from patients with BRAF inhibitor-resistant melanoma [51], indicating that HDACs are possibly involved in the development of acquired resistance to BRAF inhibitors. The gene discussed is BRAF; the disease is melanoma.